Burt A Adelman - Net Worth and Insider Trading
Burt A Adelman Net Worth
The estimated net worth of Burt A Adelman is at least $6 Million dollars as of 2024-04-25. Burt A Adelman is the Director of Verve Therapeutics Inc and owns about 428,326 shares of Verve Therapeutics Inc (VERV) stock worth over $3 Million. Burt A Adelman is the EVP, Portfolio Strategy of Biogen Inc and owns about 12,769 shares of Biogen Inc (BIIB) stock worth over $3 Million. Burt A Adelman is also the CMO & EVP, R&D of Dyax Corp and owns about 28,125 shares of Dyax Corp (DYAX) stock worth over $1 Million. Details can be seen in Burt A Adelman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Burt A Adelman has not made any transactions after 2022-05-12 and currently still holds the listed stock(s).
Transaction Summary of Burt A Adelman
Burt A Adelman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Burt A Adelman owns 4 companies in total, including Astria Therapeutics Inc (ATXS) , Dyax Corp (DYAX) , and Biogen Inc (BIIB) among others .
Click here to see the complete history of Burt A Adelman’s form 4 insider trades.
Insider Ownership Summary of Burt A Adelman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATXS | Astria Therapeutics Inc | 2016-04-05 | director |
| DYAX | Dyax Corp | 2016-01-22 | CMO & EVP & R&D |
| BIIB | Biogen Inc | 2007-10-15 | EVP & Development |
| VERV | Verve Therapeutics Inc | 2022-05-12 | director & 10 percent owner |
Burt A Adelman Latest Holdings Summary
Burt A Adelman currently owns a total of 3 stocks. Among these stocks, Burt A Adelman owns 428,326 shares of Verve Therapeutics Inc (VERV) as of May 12, 2022, with a value of $3 Million and a weighting of 42.25%. Burt A Adelman owns 12,769 shares of Biogen Inc (BIIB) as of October 15, 2007, with a value of $3 Million and a weighting of 40.77%. Burt A Adelman also owns 28,125 shares of Dyax Corp (DYAX) as of March 5, 2015, with a value of $1 Million and a weighting of 16.98%.
Latest Holdings of Burt A Adelman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VERV | Verve Therapeutics Inc | 2022-05-12 | 428,326 | 6.28 | 2,687,746 |
| BIIB | Biogen Inc | 2007-10-15 | 12,769 | 203.09 | 2,593,256 |
| DYAX | Dyax Corp | 2015-03-05 | 28,125 | 38.41 | 1,080,281 |
Holding Weightings of Burt A Adelman
Burt A Adelman Form 4 Trading Tracker
According to the SEC Form 4 filings, Burt A Adelman has made a total of 3 transactions in Verve Therapeutics Inc (VERV) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Verve Therapeutics Inc is the acquisition of 10,000 shares on May 12, 2022, which cost Burt A Adelman around $121,500.
According to the SEC Form 4 filings, Burt A Adelman has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 60,500 shares on October 15, 2007, which brought Burt A Adelman around $5 Million.
According to the SEC Form 4 filings, Burt A Adelman has made a total of 0 transactions in Dyax Corp (DYAX) over the past 5 years. The most-recent trade in Dyax Corp is the sale of 9,375 shares on March 5, 2015, which brought Burt A Adelman around $146,812.
Insider Trading History of Burt A Adelman
- 1
Burt A Adelman Trading Performance
GuruFocus tracks the stock performance after each of Burt A Adelman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Burt A Adelman is 46.81%. GuruFocus also compares Burt A Adelman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Burt A Adelman within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Burt A Adelman's insider trading performs compared to the benchmark.
Performance of Burt A Adelman
Average Return
-1.49%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.51 | 46.81 | 53.15 | -1.49 | -29.55 | |
| Relative Return to S&P 500(%) | 1.36 | 48.92 | 58.36 | 3.44 | -34.42 |
Burt A Adelman Ownership Network
Ownership Network List of Burt A Adelman
Ownership Network Relation of Burt A Adelman
Burt A Adelman Owned Company Details
What does Astria Therapeutics Inc do?
Who are the key executives at Astria Therapeutics Inc?
Burt A Adelman is the director of Astria Therapeutics Inc. Other key executives at Astria Therapeutics Inc include Chief Medical Officer Christopher Morabito , director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Business Officer Andrea Matthews .
Astria Therapeutics Inc (ATXS) Insider Trades Summary
Over the past 18 months, Burt A Adelman made no insider transaction in Astria Therapeutics Inc (ATXS). Other recent insider transactions involving Astria Therapeutics Inc (ATXS) include a net purchase of 5,204,223 shares made by Perceptive Life Sciences Master Fund Ltd , and a net sale of 20,000 shares made by Christopher Morabito .
In summary, during the past 3 months, insiders sold 20,000 shares of Astria Therapeutics Inc (ATXS) in total and bought 2,481,350 shares, with a net purchase of 2,461,350 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc (ATXS) were sold and 5,204,223 shares were bought by its insiders, resulting in a net purchase of 5,184,223 shares.
Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Astria Therapeutics Inc Insider Transactions
Burt A Adelman Mailing Address
Above is the net worth, insider trading, and ownership report for Burt A Adelman. You might contact Burt A Adelman via mailing address: Dyax Corp., 55 Network Drive, Burlington Ma 01803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
